Calculus Capital
Venture capital firm based in London, UK
Calculus Capital Investments
Calculus Capital has invested in these startups.
MIP Discovery
MIP Discovery secures £7m investment to revolutionize cell and gene therapy manufacturing with synthetic antibody alternatives, paving the way for widespread adoption of life-changing medicines. Read more
Invizius
Edinburgh's Invizius secures £950,000 to propel its groundbreaking H-Guard treatment towards revolutionizing care for dialysis patients and combating life-threatening complications! Read more
Optalitix
With $3 million in fresh funding, Optalix is set to redefine the finance software landscape, powering innovation and expansion in the insurance, banking, and healthcare sectors! Read more
Arctic Shores
Arctic Shores secures a game-changing £5.75 million in Series B funding to supercharge their innovative psychometric assessments and conquer the European market! Read more
Laverock Therapeutics
Laverock Therapeutics secures £13.5M in Seed funding to advance its groundbreaking gene silencing platform and drive advancements in regenerative medicine and immuno-oncology. Read more
Tagomics
Tagomics secures £6.7M in funding to revolutionize disease diagnosis and treatment with its cutting-edge multiomic platform, led by a powerhouse group of investors. Read more
WorkL
WorkL secures £2M Series A funding with Calculus Capital to accelerate international growth and continue revolutionizing workplace happiness on a global scale. Read more
Investments By Sector
Calculus Capital has invested in these sectors
| Biotech | 38.5% |
| Healthtech | 23.1% |
| AI | 7.7% |
| Data | 7.7% |
| HRtech | 7.7% |
